- 2-((3,5-Dinitrobenzyl)thio)quinazolinones : potent antimycobacterial agents activated by deazaflavin (F420)-dependent nitroreductase (Ddn)(2021)
Auteurs: Yanlin Jian, He Eun Forbes, Fabian Hulpia, Martijn Risseeuw, Guy Caljon, Hélène Munier-Lehmann, Helena I. M. Boshoff
Pagina's: 440 - 457
- Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors(2021)
Auteurs: Lijun Song, Romain Merceron, Fabian Hulpia, Ainhoa Lucia, Begona Gracia, Yanlin Jian, Martijn Risseeuw, Toon Verstraelen, Paul Cos, Jose A. Ainsa, et al.
- Endeavors towards transformation of M. tuberculosis thymidylate kinase (MtbTMPK) inhibitors into potential antimycobacterial agents(2020)
Auteurs: Yanlin Jian, Romain Merceron, Steven De Munck, He Eun Forbes, Fabian Hulpia, Martijn Risseeuw, Kristof Van Hecke, Savvas Savvides, Hélène Munier-Lehmann, Helena I. M. Boshoff
- Synthesis and structure activity relationships of cyanopyridone based anti-tuberculosis agents(2020)
Auteurs: Yanlin Jian, Fabian Hulpia, Martijn Risseeuw, He Eun Forbes, Hélène Munier-Lehmann, Guy Caljon, Helena I. M. Boshoff, Serge Van Calenbergh
- 1-(1-Arylethylpiperidin-4-yl)thymine analogs as antimycobacterial TMPK inhibitors(2020)
Auteurs: Yanlin Jian, Fabian Hulpia, Martijn Risseeuw, He Eun Forbes, Guy Caljon, Hélène Munier-Lehmann, Helena I. M. Boshoff, Serge Van Calenbergh
- Design and synthesis of M. tuberculosis thymidylate kinase inhibitors towards active whole-cell antimycobacterial agents(2020)
Auteurs: Yanlin Jian